Whether the dopamine D2 receptor gene (
DRD2) is associated with alcohol use disorder (AUD) and other behavioral phenotypes is a long-standing controversy. This discussion is driven by the role of 1 single-nucleotide polymorphism (SNP), rs1800497, which is located in a nearby gene,
ANKK1. This SNP, from among hundreds now known in the
DRD2 region, was assayable as a restriction fragment–length polymorphism (RFLP) in 1990, when the association of
DRD2 and other genes with alcoholism was first examined.
1 Newer technologies enabling large-scale genotyping of hundreds of SNPs in the
DRD2 region, and hundreds of thousands of SNPs genome-wide, have been applied in genome-wide association studies (GWAS) of many phenotypes, including AUD
2,3 and related phenotypes,
4 such as brain dopamine D2 binding potential.
5-7 The disproportionate focus on rs1800497 has been amplified by positive meta-analyses, such that approximately 20 studies on the association between rs1800497 and AUD have been published per decade since 1990.